[Growth hormone secretion in response to the administration of thyrotropin releasing hormone (TRH) in children with insulin-dependent diabetes mellitus]
- PMID: 1620073
[Growth hormone secretion in response to the administration of thyrotropin releasing hormone (TRH) in children with insulin-dependent diabetes mellitus]
Abstract
In this study the Authors examined the response in growth hormone (GH) to thyrotrophin releasing hormone (TRH) administration in a group composed of 29 children (17 males, 12 females) suffering from insulin-dependent diabetes mellitus (IDDM) (group 1). All subjects were prepubertal, had a chronological age of 8.82 +/- 1.76 years (m +/- SD), a bone age of 8.60 +/- 1.65 years; the time elapsed since the diagnosis was 2.45 +/- 1.51 years, glycosylated hemoglobin (HbA1c) was 7.33 +/- 1.80%. Some of the same subjects (all those with a response in GH to TRH higher than 4 ng/ml; no. 11; group 2) were examined again 12-18 months later; as controls, 13 short children were also examined (group 3). All the subjects of the three groups showed a TSH peak ranging from 10-25 microU/ml, whereas GH peak resulted higher than 4 ng/ml ("paradoxical" response) in 6 subject of the group 1 and in an only subjects of the group 2. All the responders of the 3 groups showed a value in HbA1c higher than 8%. A significant difference was not present between males and females in GH and TSH values. Cortisol levels and glycaemia remained almost constant during the performance of the tests. By considering all the groups, TSH and GH values during TRH-test were not correlated with glycaemia, chronological age, bone age, the time elapsed since the diagnosis, height, height velocity, HbA1c values. In conclusion, our data demonstrated that "paradoxical" response in GH to TRH administration was present only in some subjects and particularly in those with a poor metabolic control of the disease.
Similar articles
-
Effects of intravenous TRH on growth hormone and cortisol serum levels in children and adolescents with insulin dependent diabetes mellitus.J Endocrinol Invest. 1986 Aug;9(4):293-7. doi: 10.1007/BF03346930. J Endocrinol Invest. 1986. PMID: 3097114
-
Corticotropin-releasing hormone inhibition of paradoxical growth hormone response to thyrotropin-releasing hormone in insulin-dependent diabetics.Metabolism. 1992 Sep;41(9):949-53. doi: 10.1016/0026-0495(92)90119-u. Metabolism. 1992. PMID: 1355581
-
The growth hormone response to thyrotropin-releasing hormone in insulin-dependent diabetics involves a cholinergic mechanism.J Clin Endocrinol Metab. 1984 Oct;59(4):794-7. doi: 10.1210/jcem-59-4-794. J Clin Endocrinol Metab. 1984. PMID: 6434581
-
The paradoxical response of growth hormone (GH) to thyrotropin-releasing hormone (TRH) in constitutionally tall children involves a cholinergic pathway.J Endocrinol Invest. 1989 Sep;12(8):543-8. doi: 10.1007/BF03350756. J Endocrinol Invest. 1989. PMID: 2512341
-
[Nocturnal use of pirenzepine by a group of insulin dependent juvenile diabetics].An Esp Pediatr. 1992 Apr;36(4):261-4. An Esp Pediatr. 1992. PMID: 1605406 Review. Spanish.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical